Home/Pipeline/Export Pipeline

Export Pipeline

Various

RegistrationActive

Key Facts

Indication

Various

Phase

Registration

Status

Active

Company

Deva Holdings

About Deva Holdings

Founded in 1958, Deva Holdings has grown from a domestic Turkish pharmaceutical player into an internationally recognized, publicly traded generics and API manufacturer. Its strategy is built on vertical integration, a strong R&D focus on bioequivalence, and geographic expansion into over 80 countries. Key achievements include establishing a significant export business, maintaining a diverse portfolio spanning multiple therapeutic areas, and operating a large-scale, end-to-end production infrastructure. The company's mission, 'For lives we add health to...', underscores its commercial focus on affordable, accessible medicine.

View full company profile

Therapeutic Areas

Cardiovascular Central Nervous System Anti-infectives Oncology Supportive Care Dermatology Consumer Health

Other Various Drugs

Drug	Company	Phase	Status
New Generic Approvals	China SXT Pharmaceuticals	Application Submitted / BE Stage	Regulatory Review
New Dosage Form Development	Universe Pharmaceuticals	Development	Active
New TCM Formula Registration	Universe Pharmaceuticals	Development	Active
Bag APIs	ChemWerth	Approved	Commercial
Oral APIs	ChemWerth	Approved	Commercial
Companion Diagnostics Development	Kiffik Biomedical	Pre-clinical	Active
Portfolio of Complex Generics & 505(b)(2) Products	Alvogen	Approved/Commercial	Active
Portfolio of 40+ products	Praxgen Pharmaceuticals	Development	Active
Drug Repositioning Service	Biovista	Service	Active
Custom Control Development	Anchor Molecular	Development/Commercial	Active
Portfolio from Steriscience Partnership	Armas Pharmaceuticals	ANDA Development/Filing	Active
Generic Medicinal Products Development	Basic Pharma	Commercial	Active